Skip to main content
An official website of the United States government

Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Allen, Peter J

Duke University
United States

Preventing an Incurable Disease: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) 5R01CA235677-05 Asad Umar, D.V.M., Ph.D.
Allen, Peter J

Duke University
United States

Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas 5R01CA182076-08 Matthew Young, Ph.D.
Amuta, Ann Oyare

University Of Texas Arlington
United States

Development of Tailored, Multilevel Cervical Cancer Interventions for Ethnically Diverse Black Women 1R15CA294297-01 Goli Samimi, Ph.D., M.P.H.
Anderson, Karen S.

Arizona State University-Tempe Campus
United States

Southwest EDRN Clinical Validation Center for Head and Neck Cancer 5U01CA281660-02 Wendy Wang, Ph.D., M.Sc.
Anderson, Garnet L.

Fred Hutchinson Cancer Center
United States

NCI Cancer Screening Research Network: Coordinating and Communication Center 3UG1CA286954-02S1 Elyse LeeVan, M.D., M.P.H.
Armstrong, Gregory

St. Jude Children'S Research Hospital
United States

Sen-Survivors: An open-label intervention trial for frailty and senescence 1U01CA246510-01 Eileen Dimond, R.N., M.S.
Arnold, Corey Wells

University Of California Los Angeles
United States

Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification 5R01CA279666-02 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Atigadda, Venkatram Reddy

University Of Alabama At Birmingham
United States

Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer 5R01CA276683-03
Backman, Vadim

Northwestern University At Chicago
United States

Optical hyperspectral nanoscale chromatin analysis for colon cancer risk-stratification 1R01CA289294-01A1 Claire Zhu, Ph.D.
Badu-Tawiah, Abraham

Ohio State University
United States

Multiplexed Paper-Based Blood Test for Early-Stage Colorectal Cancer Screening 5R21CA270727-02 PAR-20-292 (R21 Clinical Trial Optional) Claire Zhu, Ph.D.